RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
RGDX was delisted on the 2nd of July, 2015.
14 hedge funds and large institutions have $42M invested in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
48% more capital invested
Capital invested by funds: $28.3M → $42M (+$13.7M)
17% more funds holding
Funds holding: 12 → 14 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sophrosyne Capital
New York
|
+$985K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$673K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.38K |
| 4 |
AIG
American International Group
New York
|
+$2.02K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$616 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
-$967K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$3K |
| 3 |
Citigroup
New York
|
-$2.59K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$549 |
RGDX Hedge Fund Activity: Q3 2013 in Review
14 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) for Q3 2013, worth a combined $42M — up 48% from $28.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RGDX positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Sophrosyne Capital, opening a new position worth an estimated $985K. The largest seller was Northern Right Capital Management, cutting an estimated $967K.
- 14 institutional investors held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) as of Q3 2013, up from 12 in Q2 2013.
- Funds reported $42M of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) stock for Q3 2013, up 48% quarter-over-quarter.
- 4 funds opened new RESPONSE GENETICS, INC COMMON SHS (DELAWARE) positions in Q3 2013 and 2 closed out, a net change of +2 holders.
- The largest RESPONSE GENETICS, INC COMMON SHS (DELAWARE) buyer in Q3 2013 was Sophrosyne Capital, an estimated $985K added.
- The largest RESPONSE GENETICS, INC COMMON SHS (DELAWARE) seller in Q3 2013 was Northern Right Capital Management, an estimated $967K sold.
Based on aggregated 13F filings for Q3 2013.